Academic Neuro Medical Oncologist

Save
You need to sign in or
create an account to save a job.

Academic Neuro Medical Oncologist,
Division of Medical Oncology and Hematology
Princess Margaret Cancer Centre, University Health Network
(Assistant/Associate/Full Professor)
Clinician Investigator, Teacher, Quality & Innovation

The Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre, University Health Network (UHN) is seeking to recruit an energetic and innovative physician with expertise in Medical Oncology, with a focus on neuro-oncology.  The anticipated start date is September 1, 2021, or shortly thereafter. 

The successful applicant will have a demonstrated passion for the medical care of cancer patients as well as a strong interest in teaching and/or quality improvement.  The successful applicant will join a multidisciplinary team in the management of patients with solid tumour malignancies and will work in collaboration with the clinical genomics and clinical trials programs, within a comprehensive cancer centre setting.  In addition, the candidate will be expected to engage in clinical, translational, or basic research. Other responsibilities include teaching at the undergraduate and postgraduate levels.

Established in 1998, The Gerry & Nancy Pencer Brain Trust Centre is a comprehensive, state-of-the-art Centre, providing the highest quality treatment, information and support for brain tumor and spinal cord patients and their families, as well as clinical and translational brain tumor research. What makes The Pencer Centre unique is its ability to provide access to a wide range of disciplines and expertise in one comprehensive site.  As a “Centre of Excellence” unlike any other, the Pencer Centre provides multidisciplinary care, treatment and support to promote translational brain tumor research.  Medical care at The Pencer Centre is provided by a wide-range of medical practitioners from a variety of disciplines. Our medical staff are internationally respected for their expertise in the treatment of primary tumors of the brain. This team of world-class physicians provide exemplary medical treatments as well as being involved in ongoing research for better, more effective treatments for these diseases. 

The Princess Margaret Cancer Centre includes the Princess Margaret Research Institute (formerly known as the Ontario Cancer Institute - OCI).  This is a world-class basic and translational research institute with particular strengths in Genomics, Immunology, Stem Cell Biology, Cancer Biology, and Cell Therapeutics. The close association between clinicians and scientists within the institution provides the opportunity for collaborations on disease biology and the development of innovative and informative translational studies, allowing the applicant to achieve the goal of bench-to-bedside medicine. In addition, the Princess Margaret Cancer Centre supports active and widely recognized clinical trials and drug development programs and maintains a state-of-the-art GMP cell processing facility. Princess Margaret is affiliated with the University of Toronto, which is world-recognized for programs in areas including Biochemistry, Immunology, Stem Cell Biology, Genomics, Proteomics, and Cell Processing, among others. Princess Margaret Cancer Centre is a teaching hospital, dedicated to educating the world’s future top cancer experts. Our role as an internationally respected teaching hospital keeps us and our students abreast of the latest medical developments and the most advanced technology. 

The successful candidate must be a Medical Oncologist and be eligible for a full time clinical academic appointment at the rank of Assistant Professor or higher.  It is expected that the candidate will be hired into one of the University of Toronto Clinician Investigator, Clinician Teacher, or Clinician Quality & Innovation tracks.  For applicants being considered for appointment as a Clinician Teacher, excellence will be assessed by the presence of scholarly contributions to teaching and education as evidenced by pedagogical innovation, curriculum development, experience in teaching at the undergraduate and graduate level, and teaching awards. For Clinician Investigators, scholarly excellence will be assessed by the presence of research grants, publications in leading journals, invited presentations at significant conferences, awards, accolades, and other related accomplishments. The applicant must also have, or be eligible for registration with the College of Physicians and Surgeons of Ontario and hold MD and FRCPC qualifications as well as Medical Oncology (or equivalent) specialist designation.  It is favorable that the successful candidate will have completed post-graduate training in Neuro-Oncology.  Academic rank, salary and contractual arrangements will be commensurate with the qualifications and experience of the successful candidate.  A highly attractive remuneration package is available.

Should you be interested in this opportunity, please forward your covering letter, curriculum vitae, and the names and addresses of three referees to:

Dr. Amit Oza - Chief, Division of Medical Oncology and Hematology
c/o Ewa Amarelo, Administrator
Princess Margaret Cancer Centre, University Health Network
Suite 7-925, 700 University Avenue, Toronto, Ontario, Canada, M5G 1Z5
Office: 416.946.4501 x 5661
Fax: 416.946.2082 E-mail: ewa.amarelo@uhn.ca

 

Applications will be accepted until July 15, 2021, or until all positions are filled.  The first rolling interviews will start after the initial July 15, 2021 applications closing date.

For more information on the Princess Margaret Cancer Centre and our world-recognized programs, visit: www.theprincessmargaret.ca

For more information about the Department of Medicine, please visit our website at: http://www.deptmedicine.utoronto.ca/

The University of Toronto is strongly committed to diversity within its community and especially welcomes applications from racialized persons / persons of colour, women, Indigenous / Aboriginal People of North America, persons with disabilities, LGBTQ persons, and others who may contribute to the further diversification of ideas. All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority.